Objectives. We aimed to study the ability of board-certified rheumatologists, blinded to all prior diagnostic test results, to establish the presence/absence of an inflammatory rheumatic disease (IRD) or RA among polyarthralgia or arthritis patients, solely relying on clinical assessment.
Introduction
Most clinicians would agree that taking a thorough medical history and performing a physical examination are the key components of establishing the correct diagnosis for many diseases [15] . In the advent of ever more precise laboratory markers and better imaging techniques, rheumatologists sometimes wonder to what extent these diagnostic tools should augment or even have already partially replaced their clinical judgement in daily clinical practice.
With the introduction of scanners that enable the depicting of soft tissues with high resolution, musculoskeletal ultrasonography has become a powerful tool to instantly image inflammatory and structural changes of joints and tendons, and often these results are available even prior to receiving the results of ordered laboratory tests. Hence some rheumatologists, especially in Germany, with >80% of respondents in an international survey published in 2012, perform ultrasonography examinations of joints as an integral part of the diagnostic workup in clinical practice [6] .
This widespread adoption of imaging and laboratory workup early in the management of patients with joint symptoms has led to a blurred line between clinical and imaging examinations in daily clinical practice, where these examinations are performed simultaneously by some rheumatologists. Therefore, nowadays, the exact diagnostic yield of solely clinically assessing patients without musculoskeletal ultrasonography to definitively diagnose inflammatory rheumatic diseases (IRDs), and especially RA, has been debated among experts [4, 7] . While some emphasize that visualizing the amount of synovitis in joints and tendon sheets of clinically symptomatic and asymptomatic joints can greatly enhance the ability to diagnose RA [7, 8] , others point out that in most of the examined patients the diagnosis could have been reached without performing musculoskeletal ultrasonography [4] .
As specialists, rheumatologists are rarely the first physicians patients turn to with new symptoms indicating a possible IRD. Therefore most patients seen in daily clinical practice provide the rheumatologist with the results of externally obtained tests and imaging. Thus the diagnostic accuracy of a solely clinical assessment (only obtaining a medical history and performing a physical examination) to diagnose a patient with RA cannot be studied reliably by just observing rheumatologists in daily clinical practice, because of bias introduced to clinical judgement by preeminent external laboratory test and imaging results.
We aimed to prospectively study the contribution of solely clinical assessment (taking a medical history and performing a physical examination focused on joint symptoms) compared with a diagnostic workup including ultrasonography of selected joints and results of laboratory tests for establishing the diagnosis of an IRD and the diagnosis and classification of RA in patients with thus far unexplained joint symptoms.
Methods

Study design
We performed a prospective, examiner-blinded study documenting the diagnostic work of board-certified rheumatologists with long-standing experience in musculoskeletal ultrasonography in a convenience cohort of 100 patients referred for diagnostic workup to a tertiary care rheumatology centre.
Patients were recruited into the study at the time of their hospital admission if they had not yet received a rheumatologist-established diagnosis of an IRD, had not been treated with conventional or biologic DMARDs and reported a history of or present arthralgia of at least five peripheral joints and/or reported a history of or present swelling of at least one joint with an overall symptom duration of no longer than 2 years. Prior treatment with NSAIDs and corticosteroids was permitted and the extent of such pretreatment was categorically recorded.
All patients provided written consent after receiving oral and written information about the study by one of the four authors. The study was reviewed and approved by the institutional review board/ethics committee of the University Medical Center of Regensburg (07/125). The study was conducted in compliance with the Declaration of Helsinki, International Conference on Harmonization Good Clinical Practice guidelines and local country regulations.
Participants were instructed not to provide any unsolicited information pertaining to their prior external diagnostic workup, other pre-existing rheumatic diseases or prior drug treatment to the second rheumatologist conducting the diagnostic evaluation.
The second rheumatologist (one of the authors: B.E., G.P. or W.H., all board-certified rheumatologists), with a mean of 16 years of clinical experience and a mean of 10 years of experience in musculoskeletal ultrasonography, was always different from the rheumatologist that had obtained the informed consent and was therefore blinded to all prior externally conducted diagnostic workups and performed and documented the following four sequential steps: (1) obtaining a medical history focused on the joint-related symptoms, (2) performing a physical examination focused on joint-related signs, (3) conducting musculoskeletal ultrasonography of selected peripheral joints and (4) arriving at a final judgement, including results of laboratory tests.
After each of the four steps the blinded rheumatologist reported the time required for the step and the degree of certainty for establishing the diagnosis of an IRD and of RA using four pre-defined categories (definite, probable, possible, absent) and the presence of probable (>10% possibility) differential diagnoses. Furthermore, for the last three of the four evaluation steps, fulfilment of the ACR/EULAR RA classification criteria from 2010 was recorded [9] .
After the evaluation by the blinded examiner, patients received their scheduled thorough workup as part of the standard in-patient clinical care in our institution. We defined the rheumatic diagnosis reported on the discharge summary report as the final diagnosis for each patient. After having completed and documented their four-step research evaluation, the three blinded rheumatologists (B.E., G.P. and W.H.) contributed later to the routine clinical care of some of the patients, but to prevent bias, all discharge diagnoses were adjudicated by the fourth author (M.F.) as part of his responsibilities as head of the department during routine clinical care.
Medical history
The medical history obtained by the blinded rheumatologist focused on symptoms pertaining to rheumatic inflammatory diseases, especially typical symptoms of RA. The examiners were instructed to not inquire about externally performed diagnostic tests, suspected or given diagnoses of rheumatic diseases and specific information about prior medications to treat rheumatic symptoms of the patient. Despite these protocol-imposed limitations, the pre-recorded categorical information about current or prior use of NSAIDs and https://academic.oup.com/rheumatology corticosteroids was available to the blinded examiner. The examiner recorded the time spent and information obtained regarding involved joints, symmetrical joint symptoms, morning stiffness of joints, presence of inflammatory back pain, psoriasis, RP, preceding infections, classical symptoms of gouty arthritis and family history for RA in pre-specified categories on a single-page study documentation sheet.
Physical examination
The physical examination performed by the blinded examiner was focused on signs of peripheral arthritis. Tender (68 joints) and swollen (66 joints) joint counts were documented on provided graphical representations. Additionally, the absence or presence of clinical signs of tenosynovitis for each hand and each foot was recorded. If deemed clinically necessary by the examiner, Menell's test for sacroiliitis could be performed and documented for each sacroiliac joint.
Musculoskeletal ultrasonography
All of the ultrasonography examinations were performed on a Logiq E9 device (GE Healthcare, Buckinghamshire, UK) with an ML6-15 linear probe (615 MHz frequency) for larger joints and a linear hockey stick probe (818 MHz frequency) for joints of the fingers and toes. The technical parameters of the examination included a greyscale frequency of 15 MHz, pulse repetition frequency of 600 Hz and a colour Doppler frequency of 7.5 MHz, with highest gain level without background noise and a low wall filter.
Examiners were asked to evaluate at least the seven joints included in the published US7 score [10] of the clinically most affected hand and foot: the wrist joint, the MCP joints and PIP joints of digits 2 and 3 and the MTP joints of digits 2 and 5. If deemed necessary in view of the particular symptoms of the patient, the blinded examiner could evaluate additional joints. For each joint evaluated, a semiquantitative score (range 03) was used to rate the extent of synovitis detected by greyscale ultrasonography and hyperperfusion by colour Doppler ultrasonography. Additionally, the presence or absence of erosions and/or tenosynovitis of tendons adjacent to the joint were also documented on the single-page documentation sheet [10] .
Laboratory tests
All patients were admitted for inpatient routine clinical care to our rheumatology department and therefore all study participants received a preset core panel of laboratory tests including, among other parameters, ESR [abnormal values stratified by age (younger/older than 50 years): >15/>20 for men and >20/>30 mm/h for women], CRP (abnormal values >5.0 mg/l), RF (abnormal values >14 U/l), antibodies against anti-CCP (abnormal values >17 U/l), antibodies against antimutated citrullinated vimentin (abnormal values >20 U/l), ANA (abnormal titre >1:40) and ANCA.
Statistical analyses
Due to the exploratory nature of our study, we performed no formal sample size calculation prior to and no screening log during enrolment of the convenience sample of 100 patients.
The two co-primary endpoints of our study were to determine the ability of board-certified rheumatologists to definitively diagnose or exclude (accuracy) an IRD and RA solely relying on clinical assessment without utilizing the results of musculoskeletal ultrasonography and laboratory tests. We defined accuracy in the setting of our study as the sum of the proportion of patients correctly identified as having a definite diagnosis of the disease combined with the proportion of patients correctly identified as not having the diagnosis ('absent' diagnosis). Secondary analyses were performed by dichotomizing the observed data [definite or probable (diagnosis) vs possible or absent (no diagnosis)] and comprehensive diagnostic test statistics (sensitivity, specificity, positive and negative likelihood ratios and predictive values and k statistic) were reported for each of the sequential diagnostic steps of the blinded rheumatologists.
Additionally, demographic factors, inclusion criteria, pretreatment and information obtained and time spent during the four steps of the blinded diagnostic workup were compared among patients receiving the final discharge diagnosis of RA, IRD other than RA (IRD not RA) and non-IRDs (non-IRD). Statistical comparisons were performed utilizing chi-square or Fischer's exact test for categorical variables and non-parametric MannWhitney U test for continuous variables.
Results
In the period from 8 September 2014 to 15 October 2015, 100 patients on 70 separate days (13 patients of the on average 12 patients admitted per weekday to our institution) were recruited into the study. Demographic data, symptoms pertaining to the specified inclusion criteria, pretreatment with NSAIDs and/or corticosteroids and the final diagnosis reported in the discharge summary of the routine clinical inpatient workup are presented in Table 1 .
Of the 75 patients (75%) with a final discharge diagnosis comprising an IRD, 43 were diagnosed with RA. Of these 43 patients, 11 (25.6%), despite receiving the diagnosis, did not fulfil the ACR/EULAR classification criteria for RA from 2010. Reasons given for establishing the diagnosis despite the lack of fulfilment of classification criteria in these 11 discharge summaries were typical findings for RA on MRI of a hand (n = 6), polyarthritis of small joints not involving >10 joints in anti-CCP-and RF-negative patients (n = 4) and lack of synovitis due to prednisolone pretreatment (n = 1). The most common diagnoses among patients with an IRD other than RA were crystal arthropathy, undifferentiated and PsA and among patients with non-IRDs the most common diagnoses were OA, FM and arthralgia of unknown cause, despite the thorough inpatient workup (Table 1) .
Three of the authors performed the blinded stepwise evaluation of the patients and spent a median time of 5 min (range 38) taking the medical history, 5 min (range 210) on performing the physical examination and 10 min (range 516) min for the musculoskeletal ultrasonography.
The main findings in each diagnostic step are presented stratified by the type of final diagnosis in Table 2 . Findings that differed highly significantly (P < 0.01) between patients with RA and IRD other than RA were a history of PIP joints ever involved, the ratio of joints examined by greyscale sonography with synovitis and laboratory evidence of RF, anti-CCP and anti-MCV antibodies. Findings that differed highly significantly (P < 0.01) between patients with an IRD and non-IRD were the age and symptom duration at presentation, the self-reported swelling of at least one joint, finding of a swollen joint(s), tenosynovitis and a positive Menell's test on the physical examination, the ratio of diseased among all or all of the US score evaluating 7 joints (clinically dominant hand: wrist joint, MCP and PIP joints of digits 2 and 3; clinically dominant foot: MTP joints of digits 2 and 5) examined by ultrasonography or the detection of any joints with synovitis (by greyscale sonography) or hyperperfusion (by colour Doppler sonography) and laboratory evidence of elevated ESR or CRP.
Although not part of the blinded evaluation and the study protocol, the results of radiographs of the hands and feet and MRI of joints performed for routine clinical care were retrieved from charts. Hand radiographs were performed for the majority of patients (n = 90) and depicted erosions proving RA in 1 patient and were suggestive for RA in an additional 17 patients (13 of those were later diagnosed with RA). Radiographs of both feet were performed in 91 patients and depicted erosions proving RA in 1 patient and were suggestive for RA in an additional 7 patients (6 of those were later diagnosed with RA). Twelve patients with RA, 9 patients with IRD other than RA and 14 patients with non-IRD received MRI of selected joints, of whom 6, 0 and 0 showed typical signs and 4, 1 and 0 had suggestive signs of RA, respectively.
The observed diagnostic certainties of the rheumatologists after each step of the blinded workup to diagnose RA or an IRD are reported in Table 3 and to delineate RA patients only among the subset of IRD patients are reported in Table 4 . The ability to correctly arrive at or rule out the diagnosis of an IRD (accuracy) increased from 14% after the medical history, 27% after the physical examination and 53% after the US to 70% after taking laboratory test results into account. Of note, only 1 (4%) of the 25 patients with a final diagnosis of a non-IRD in the discharge summary was falsely classified as having an IRD in the clinical assessment of the blinded rheumatologist.
The corresponding values for each step for correctly identifying patients with or without RA were 8, 19, 42 and 60%, respectively. Therefore the diagnostic accuracy of solely clinical assessment for determining the definite diagnosis of RA in our cohort was only 19%. Pretreatment with corticosteroids (in the prior 7 days) vs none did not alter these results substantially (15 vs 20%). Taking the results of ultrasonography and laboratory tests into account, the diagnostic accuracy for RA increased to 42 and 60%, respectively.
In the secondary analyses utilizing dichotomized results, the diagnostic test statistics also displayed a marked improvement of the precision of the diagnoses after taking the ultrasonography results into account. The positive likelihood ratio to detect RA increased from step 2 (clinical assessment) to step 3 (clinical assessment and ultrasonography) from 3.1 to 4.8, but the next step-adding the laboratory results-only lead to a marginal further increase to 5.2.
After each step (physical examination, ultrasonography and taking laboratory test results into account) the blinded rheumatologists documented if the ACR/EULAR classification criteria for RA had been met. Of the 43 patients receiving a final diagnosis of RA, 10 (23%), 11 (26%) and 26 (61%) fulfilled the classification criteria, respectively. Of note, some patients with the final diagnosis of an IRD other than RA [4 of 32 (13%)] and with non-IRD [6 of 25 (24%)] formally fulfilled these criteria. 
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The ability of rheumatologists, blinded to all prior external diagnostic results, to detect/rule out RA or IRDs as established consecutively by in-patient workup in routine clinical care among 100 patients admitted for arthralgia and/or arthritis symptoms. The observed data are provided stratified by the four diagnostic steps performed [medical history (MH), physical examination (PE), musculoskeletal ultrasonography (US) and laboratory tests (LT)]. Accuracy: proportion of patients with either correct definite diagnosis (n, formatted bold) or correct absent diagnosis (n, formatted bold italic) among all patients); sensitivity: true positive rate; specificity: true negative rate; +LR: positive likelihood ratio; ÀLR:
negative likelihood ratio;
TABLE 4
The ability of rheumatologists, blinded to all prior external diagnostic results, to detect/rule out RA among the subset of 75 patients with inflammatory rheumatic diseases 
Discussion
Although most clinicians agree that taking a thorough medical history and performing a physical examination are the key components of establishing the correct diagnosis for many diseases [1, 2] , the widespread adoption of imaging and laboratory workup in the management of patients presenting with joint symptoms has led to a blurred line between a purely clinical assessment and the combined evaluation of clinical findings in the context of imaging and laboratory test results in daily routine practice. The exact contribution of just clinically assessing patients without relying on results of imaging and laboratory tests to diagnose IRD, and especially to diagnose RA, has been subject to debate among experts [15, 7] . To our knowledge, this is the first examiner-blinded study evaluating patients referred to a tertiary rheumatology centre for a thorough inpatient workup of joint symptoms to elucidate the contribution of each workup step separately for establishment of the diagnosis of IRD in general and RA in particular.
We found that in the context of patients referred to a tertiary referral centre for the evaluation of thus far unexplained joint symptoms lasting not longer than 2 years, performance of a clinical assessment by an experienced rheumatologist relying only on a joint-focused medical history and physical exam established or ruled out the correct diagnosis in only a minority of patients. Contrary to our expectation, these results did not improve substantially in the subgroup of patients who had not received any pretreatment with corticosteroids. As expected from other research, the ratio of correct classification in regard to IRD and RA improved markedly when taking the results of ultrasonography into account, and even further when laboratory test results were included [11] .
Despite a thorough literature review, we were unable to find other studies explicitly blinding examiners to external laboratory and imaging results prior to the clinical evaluation of arthralgia patients with which to compare our results. Although not formally blinded to prior diagnostic results, a retrospective Dutch study utilizing data from the Leiden University rheumatic outpatient clinic from 2012 to 2013 evaluated 1934 patients with new-onset arthralgia, of whom 145 patients were classified only by clinical evaluation to have clinical significant arthralgia and 1791 unexplained arthralgia without utilizing imaging or laboratory results [5] . In the following 12-month period 4.0 vs 0.2%, respectively, of these patients progressed to RA, classified by the 1987 ACR criteria, demonstrating the ability of rheumatologists do define high-risk patients among arthralgia patients only by clinical evaluation.
Most studies evaluating the utility of ultrasonography for diagnosing IRD or RA were conducted among outpatients presenting to an early arthritis clinic (review of published studies 19822015 [7] ). While one British study failed to demonstrate a significant improvement in the prediction of which arthralgia patients progressed to persistent inflammatory arthritis when ultrasonography was added to the clinical and laboratory workup [4] , all the other 14 studies found meaningful improvement of the diagnostic accuracy utilizing ultrasonography [3, 8, 1223] . For example, in a recent Swedish study [8] , the diagnostic certainty for the diagnosis of an inflammatory arthritis increased from 33 to 72% when adding ultrasonography to the clinical and laboratory evaluation of 103 patients, demonstrating a finding similar to our study.
The strength of our study was the examiner-blinded design and that only experienced, board-certified rheumatologists performed all steps of the evaluation. Additionally, the way all evaluations (symptom-focused history taking, physical examination focused on joint symptoms, ultrasonography informed by findings of the physical examination) were performed similarly to routine clinical care, thus increasing the applicability of our results.
The generalizability of our findings was limited due to the recruitment of only patients sent for an inpatient workup to a single tertiary referral centre. Therefore the studied cohort might represent a more diagnostically challenging cohort and may have had a much higher prevalence of RA and IRD than one would find in the classical setting of an early arthritis outpatient clinic. Nevertheless, the median symptom duration of 4 months among the 43 patients diagnosed with RA confirmed that the studied cohort contained a majority of patients with very early RA. The final diagnosis used in this cross-sectional study was established by retrieving the discharge diagnosis of the included patients. In comparison to other studies, no longitudinal follow-up of the patients was performed to further strengthen the validity of these discharge diagnoses. Therefore some of the patients in our study incorrectly diagnosed by the blinded rheumatologist as having RA could develop more clinical evidence later and would then receive an RA diagnosis during follow-up.
Taking the results of a recent publication of MRI findings of the wrists in healthy adults into account (not yet available during the evaluation of the patients in this study) [24] , an overinterpretation of mild signs of synovitis and limited numbers of erosions as proof of manifest RA and therefore misclassification of a minority of the included patients is possible.
Conclusion
We conclude that experienced rheumatologists, in the setting of our cross-sectional study, only judging from a brief joint-symptom focused medical history and clinical examination and being deprived of information on external imaging and laboratory workup by blinding, were unable to correctly classify the majority of patients presenting with arthralgia or arthritis symptoms for inpatient workup as suffering from inflammatory arthritis or RA.
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